Let's Talk ID

IDSA COVID-19 Guidelines co-author Amy Shumaker, PharmD and current co-chair of the HIVMA/IDSA HIV Primary Care Guidance Melanie Thompson, MD discuss recently issued guidance on Paxlovid, including managing drug interactions.

Emergency medicine physician Heatherlee Bailey, MD, FAAEM, FCCM of the Durham VA Medical Center and family medicine physician Scott Hartman, MD of the University of Rochester Medical Center discuss the latest COVID-19 vaccine booster recommendations. *This episode was recorded on May 17, 2022 and produced in partnership with the American Academy of Family Physicians and the Society of Critical Care Medicine. 

Dr. Kathleen Bell, Professor and Chair of the Department of Physical Medicine and Rehabilitation at UT Southwestern Medical Center, and Dr. Nahid Bhadelia, associate professor of infectious diseases at Boston University School of Medicine and founding director of the BU Center of Emerging Infectious Diseases Policy and Research, discuss the latest research and information on long COVID. 

In this rebroadcast of the COVID-19 Real-Time Learning Network’s Cultural Awareness Series, Gayathri Krishnan, MBBS, MD, Arghavan Salles, MD, PhD, and Laila Woc-Colburn, MD, DTM&H, FIDSA and moderator Mati Hlatshwayo Davis, MD, MPH discuss the representation of women in medicine, the impact the pandemic has had on women in the workforce and overcoming barriers to advancement.

IDSA President Daniel McQuillen, MD, FIDSA is joined by CDC Director Rochelle P. Walensky, MD, MPH, FIDSA to discuss the current state of the COVID-19 pandemic and the pivotal role of infectious disease physicians.

IDSA members Archana Chatterjee, MD, FIDSA of Rosalind Franklin University and Myron Cohen, MD, FIDSA of UNC Chapel Hill share insight on COVID-19 vaccines and prevention in immunocompromised individuals, including current recommendations and the role of antibody testing.

IDSA COVID-19 Guidelines co-authors Rajesh Gandhi, MD, FIDSA and Adarsh Bhimraj, MD, FIDSA provide the latest information on COVID-19 treatments, including the potential role of combination therapies, newer therapies such as nirmatrelvir and strovimab, and their thoughts on President Biden's "Test to Treat" initiative.   

Last fall, the IDSA Board of Directors took a fresh look at IDSA’s strategic plan, understanding that now is the time to seize the moment as the important contributions of the ID workforce during the pandemic are front and center. In this episode, IDSA President Daniel McQuillen, MD, FIDSA, IDSA Vice President Steven Schmitt, MD, FIDSA of the Cleveland Clinic, IDSA Treasurer Jeanne Marrazzo, MD, FIDSA of the University of Alabama at Birmingham and IDSA AMR Committee Chair Emily Spivak, MD, FIDSA of the University of Utah discuss three initiatives in which the Board approved significant investments and how they will positively impact the field of ID.

In this rebroadcast of the COVID-19 Real-Time Learning Network’s Cultural Awareness series and in honor of Black History Month, Associate Editor and St. Louis Medical Director Dr. Mati Hlatshwayo Davis speaks with Dr. Taison Bell of the University of Virginia and Dr. Stella Safo of Mount Sinai on the impact that historical medical mistrust among Black communities has had on vaccine uptake. The panelists share examples of trusted messengers effectively engaging in conversations about COVID-19 vaccines within their communities.

The COVID-19 pandemic has brought health disparities to the forefront of public health. In this episode, Emily Spivak, MD, FIDSA of the University of Utah, and HIVMA Vice Chair Allison Agwu, MD, FIDSA of Johns Hopkins University discuss what’s currently being done to reduce the disparate impact of COVID-19 on certain populations and the changes that need to be made in order to achieve health equity.